abstract |
The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthesis methods for preparing such compounds, methods for inhibiting DPP-IV by using such compounds and pharmaceutical formulations containing them for the treatment of DPP-IV mediated diseases, especially type 2 diabetes. |